Date: 2011-02-22
Type of information: Collaboration agreement
Compound: Kinomed partnership
Company: IOTA Pharmaceuticals (UK) KinaseDetect (Denmark) SARomics Biostructures (Sweden)
Therapeutic area:
Type agreement: collaboration
Action mechanism:
Disease:
Details: IOTA Pharmaceuticals, KinaseDetect and SARomics Biostructures have established the Kinomed Partnership to accelerate human protein kinase drug discovery. This partnership is funded by the Eurostars program of the European Union. Kinomed has been established to provide an integrated package of services for protein kinase inhibitor discovery and development. Kinase production, kinase assay development, kinase crystal structure determination, kinase fragment library construction, hit finding and optimisation, in silico screening, kinase biochemical and biophysical screening, structure- and ligand-based drug design and medicinal chemistry services are all included within a single, state-of-the-art offering.
Financial terms:
Latest news:
